Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Androgenetic alopecia is more common in male Chinese adolescents and linked to rosacea, but doesn't affect quality of life.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Severe scars need a mix of treatments for best results.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

More people are seeing dermatologists for hair and scalp problems now than in the past.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Youth in Kashmir Valley, India, are likely to experience depression due to conflict and stressful conditions.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.